These include persistent low-grade inflammation, cytokine dysregulation, and activation of oncogenic signaling pathways such as NF-κB, JAK–STAT, and MAPK, all of which are implicated in colorectal cancer development [2,5,15]. The gene discussed is NFKB1; the disease is colorectal cancer.